CN113421639A - Clinical pathway formation system, method, and corresponding apparatus and storage medium - Google Patents
Clinical pathway formation system, method, and corresponding apparatus and storage medium Download PDFInfo
- Publication number
- CN113421639A CN113421639A CN202110459519.6A CN202110459519A CN113421639A CN 113421639 A CN113421639 A CN 113421639A CN 202110459519 A CN202110459519 A CN 202110459519A CN 113421639 A CN113421639 A CN 113421639A
- Authority
- CN
- China
- Prior art keywords
- disease
- clinical
- label
- clinical pathway
- hospital
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000037361 pathway Effects 0.000 title claims abstract description 192
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000015572 biosynthetic process Effects 0.000 title claims description 14
- 201000010099 disease Diseases 0.000 claims abstract description 162
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 162
- 230000004044 response Effects 0.000 claims abstract description 6
- 238000011282 treatment Methods 0.000 claims description 35
- 238000004364 calculation method Methods 0.000 claims description 10
- 238000004590 computer program Methods 0.000 claims description 10
- 238000003759 clinical diagnosis Methods 0.000 claims description 8
- 230000006870 function Effects 0.000 claims description 7
- 238000012552 review Methods 0.000 claims description 6
- 238000012790 confirmation Methods 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 238000011161 development Methods 0.000 abstract description 4
- 238000011272 standard treatment Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 description 24
- 206010002091 Anaesthesia Diseases 0.000 description 9
- 230000037005 anaesthesia Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 7
- 230000006399 behavior Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses a clinical pathway forming system, a method, a corresponding device and a storage medium, wherein the system comprises modules respectively used for: determining whether there is a disease-specific clinical pathway for a disease species; in response to determining a special disease clinical pathway with the disease category, calculating the utilization rate of each special disease clinical pathway label according to a pre-constructed special disease clinical pathway label; generating a first special disease recommendation removal and/or inclusion and/or replacement label according to the calculated utilization rate of each special disease clinical path label and a first preset special disease criterion; modifying the disease specific clinical pathway according to the first disease specific recommendation by removing and/or including and/or replacing a label and treating the modified disease specific clinical pathway as an in-hospital clinical pathway. The invention can automatically form or update clinical paths meeting actual and development requirements, and realize standard treatment and accurate cost control.
Description
Technical Field
The present application relates to the field of electrical digital data processing, and more particularly to clinical pathway formation systems, methods, and corresponding devices and storage media.
Background
The Clinical pathway (Clinical pathway) refers to a standardized set of treatment modalities and procedures established for a disease/disease species. The medical behavior is controlled through the clinical path, and the effects of standardizing the clinical diagnosis and treatment behavior, ensuring the medical quality and safety and reducing the cost can be achieved. The national health record committee has released more than 1000 clinical routes of diseases for all levels of hospitals to refer to at present, and the clinical routes are used for guidance of medical process, control and management of medical quality, and has brought relevant contents of clinical route management into performance assessment management, and relevant indexes of clinical routes such as access rate of clinical routes, average number of days of hospitalization of single disease category, average cost of single disease category and the like will influence performance scoring of hospitals.
Based on the clinical path published by the country, a plurality of hospitals are improved on the basis of the clinical path, and the clinical path of each hospital is formed for in-hospital management and control, but most diagnosis and treatment items in the clinical path are obtained based on expert consensus discussion or guidelines and lack of data support, and meanwhile, with the continuous development of medical technology and the continuous updating and refining of disease diagnosis and treatment schemes, in the practical application of the current clinical path, a phenomenon that a patient needs to apply a large number of items outside the clinical path often occurs, which also indicates that the currently used clinical path cannot be suitable for the development and change of disease diagnosis and treatment, and needs to be continuously optimized and updated to improve the path entry rate and the management and control effect.
In addition, the establishment of clinical routes in countries and hospitals also aims to design optimal medical and care plans by disease category. The diagnosis and treatment operation which needs to be carried out conventionally in the diagnosis and treatment process is standardized, unnecessary and unreasonable diagnosis and treatment behaviors are reduced, the hospitalization time is standardized, the medical resource consumption is rationalized, and the increase of medical expenses is controlled. However, although clinical path forms published by countries and hospitals include diagnosis and treatment items of applicable objects, diagnoses and various diagnosis and treatment stages, specific medicines, consumables and cost for selecting diagnosis and treatment schemes do not have a clear guidance scheme, and particularly, no diagnosis and treatment items and specific medicine and consumable guidance schemes are provided for scenes with high resource consumption such as operations and anaesthesia. This also makes traditional clinical route can't control operation, resource consumption and the action of diagnosing under anesthesia, for the action of diagnosing mentioned in clinical route, can't control the resource consumption under the action of diagnosing, cause each department, each doctor to consume the difference great, can't do accurate accuse and spend.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a clinical pathway forming system, a method, corresponding equipment and a storage medium, which can automatically form or update clinical pathways meeting actual and development requirements, and realize standard treatment and accurate fee control.
In a first aspect of the invention, there is provided a clinical pathway formation system, the system comprising:
a specific disease clinical pathway determination module for determining whether a specific disease clinical pathway of a disease category exists, wherein the specific disease clinical pathway is one of national edition clinical pathways;
the first special clinical path label utilization rate calculation module is used for responding to the special clinical path with the disease category and calculating the utilization rate of each special clinical path label according to a pre-constructed special clinical path label, wherein the special clinical path label represents a clinical diagnosis and treatment item and is respectively matched with the charging items or medical advice data of the disease category of a corresponding hospital, and each charging item or medical advice can only correspond to one special clinical path label;
the first special clinical pathway label recommendation module is used for generating first special clinical recommendation removal and/or inclusion and/or replacement labels according to the calculated utilization rate of each special clinical pathway label and a first preset special criterion;
a first nosocomial clinical pathway generation module to remove and/or incorporate and/or replace the label according to the first disease-specific recommendation to modify the disease-specific clinical pathway and take the modified disease-specific clinical pathway as the nosocomial clinical pathway.
In an embodiment, the system further comprises: an nosocomial clinical pathway determination module to determine whether there is an nosocomial clinical pathway of the disease category; the hospital clinical path label utilization rate calculation module is used for responding to the determination of the hospital clinical path with the disease category, and calculating the utilization rate of each hospital clinical path label according to the pre-constructed hospital clinical path label, wherein the hospital clinical path label represents clinical diagnosis and treatment items and is respectively matched with charge items or medical order data of the disease category of the corresponding hospital, and each charge item or medical order can only correspond to one hospital clinical path label; the hospital clinical pathway label recommendation module is used for generating a hospital recommended removal label and/or an inclusion label and/or a substitution label according to the calculated utilization rate of each special disease clinical pathway label and the utilization rate of each hospital clinical pathway label and a preset hospital criterion; an in-hospital clinical pathway update module to update the in-hospital clinical pathway according to the in-hospital recommendation removal and/or inclusion and/or replacement label.
In an embodiment, the system further comprises: the second special clinical pathway label utilization rate calculation module is used for responding to the special clinical pathway without the disease category and calculating the utilization rate of each special clinical pathway label according to a pre-constructed special clinical pathway label; the second special disease clinical path label recommending module is used for generating a second special disease recommendation inclusion label according to the calculated utilization rate of each special disease clinical path label and a second preset special disease criterion; and the second nosocomial clinical pathway generation module is used for generating a nosocomial clinical pathway according to the second special disease recommendation inclusion label.
In an embodiment, the system further comprises an expert commenting module for accepting a secondary confirmation of the recommended tags by the expert.
In an embodiment, the system further comprises a review module for reviewing at least the calculated clinical pathway label usage results.
In a second aspect of the invention, there is provided a method of clinical pathway formation, the method comprising:
determining whether a disease-specific clinical pathway exists for a disease category, wherein the disease-specific clinical pathway is one of national edition clinical pathways;
in response to determining a disease-specific clinical pathway with the disease category, calculating the utilization rate of each disease-specific clinical pathway label according to pre-constructed disease-specific clinical pathway labels, wherein the disease-specific clinical pathway labels represent clinical treatment items and are respectively matched with charge items or medical order data of the disease category of a corresponding hospital, and each charge item or medical order can only correspond to one disease-specific clinical pathway label;
generating a first special disease recommendation removal and/or inclusion and/or replacement label according to the calculated utilization rate of each special disease clinical path label and a first preset special disease criterion;
modifying the disease specific clinical pathway according to the first disease specific recommendation by removing and/or including and/or replacing a label and treating the modified disease specific clinical pathway as an in-hospital clinical pathway.
In a third aspect of the invention, a computer device is provided, comprising a processor, a memory and a computer program stored on the memory and executable on the processor, wherein the processor, when executing the computer program, implements the functions of the system according to the first aspect of the invention or implements the steps of the method according to the second aspect of the invention.
According to a fourth aspect of the present invention, there is provided a computer readable storage medium having stored thereon a computer program which, when executed by a processor, carries out the functions of the system according to the first aspect of the present invention or the steps of the method according to the second aspect of the present invention.
According to the invention, based on the use condition of the clinical path label constructed by calculating the past data of the disease species, compared with the existing clinical path, an optimization scheme conforming to the diagnosis and treatment characteristics of the hospital is generated, and the effects of expanding the application range of the clinical path, standardizing the operation of a doctor and improving the access rate of the disease species are realized. Meanwhile, the clinical path can be refined to a medication scheme, a consumable material category, a control expense range and the like, the expense control effect of the clinical path is improved, and the purposes of ensuring the medical quality and reducing the medical cost are achieved. Specifically, the beneficial effects of the invention compared with the existing scheme include:
1) based on the past data, the clinical path is optimized, the uncommon diagnosis and treatment items are removed and are brought into the common diagnosis and treatment items, so that the formulation of the clinical path is more scientific and accords with the actual condition of a hospital;
2) the method can calculate and present the using conditions of doctors and departments of diagnosis and treatment items in the existing clinical path, help the hospital to visually see the using preference of the doctors and departments for the diagnosis and treatment items at present, and find out abnormal diagnosis and treatment behaviors in time;
3) and organizing experts for the recommended results which are different from the original paths to perform comment, and referring to the expert opinions to obtain the final optimization scheme result, so that the data measurement and calculation are combined with clinical experience.
Other features and advantages of the present invention will become more apparent from the detailed description of the embodiments of the present invention when taken in conjunction with the accompanying drawings.
Drawings
FIG. 1 is a block diagram of one embodiment of a system according to the present invention;
fig. 2 is a flow chart of an embodiment of a method according to the present invention.
For the sake of clarity, the figures are schematic and simplified drawings, which only show details which are necessary for understanding the invention and other details are omitted.
Detailed Description
Embodiments and examples of the present invention will be described in detail below with reference to the accompanying drawings.
The scope of applicability of the present invention will become apparent from the detailed description given hereinafter. It should be understood, however, that the detailed description and the specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only.
FIG. 1 shows a block diagram of a preferred embodiment of a clinical pathway formation system in accordance with the present invention. The system comprises:
and the disease species selection module 102 is used for selecting the disease species needing to be optimized or generating the clinical path according to the self requirements by the academies or researchers.
A disease specific clinical pathway determination module 104 for determining whether there is a disease specific clinical pathway for the selected disease category, wherein the disease specific clinical pathway refers to a national version of the clinical pathway promulgated by the national council.
The first specific clinical path tag usage rate calculation module 106 is configured to calculate, when a specific clinical path with a selected disease category is determined, a usage rate of each specific clinical path tag according to a pre-constructed specific clinical path tag, where the specific clinical path tag represents a clinical diagnosis and treatment item and is respectively matched with a charging item or medical order data of the selected disease category of a corresponding hospital.
The specific clinical pathway label can be constructed as follows. For the diagnosis and treatment items related in the clinical path of the disease category (selected disease category) of the national edition, the item names in the clinical path of the disease category of the national edition are used as the names of all labels, and the charging items/medical advice data related to the disease category are matched to all the labels. For the items not related to the national version of the disease clinical pathway, the standardized classification is carried out according to the following standardized rules, names are created by referring to the national clinical pathway expression mode, and the charging items or medical orders are matched to the labels. One tag may contain multiple charge items or multiple orders, but one tag may contain only charge items or orders, not both, and one charge item/order may correspond to only one tag.
The national version of the item not covered by the clinical pathway of the disease category can construct a label name and match the billing item/order according to the following standardization rules. The clinical path labels of the special diseases to be constructed are divided into three categories of consumables, medicines and medical service items. For example, the pharmaceutical products may be classified according to their categories by referring to the catalog of national medicals 2019, and the label names may be expressed as pharmaceutical product categories (e.g., anti-acid drugs, anti-emetic drugs, etc.) by referring to the national clinical pathway expression. For consumables, for example, refer to "medical device classification catalog", and classify the billing items classified as consumables according to categories, and preferentially adopt a certain medical item object (such as an oxygen inhalation object, an infusion object, etc.) related to a label, and if there is no corresponding medical item consumable, the label name is expressed as a consumable category (such as a dressing, a hemostatic material, etc.). For the medical service items, firstly, the medical orders except for the description medical orders in the medical order detail table are standardized, and the expression modes of the medical orders are standardized to form standardized medical orders. All orders (or at least covering examinations, electronic application forms, consultation orders) other than the description order are then classified, and the label names are expressed as medical items (e.g., abdominal ultrasound, aerosol inhalation, etc.) with reference to the national clinical pathway expression. Whether the standardized medical advice covers all the charging items of which the categories are medical service items or not is judged by applying the mapping relation table of the medical advice and the charging items, for the charging items without the corresponding standardized medical advice, for example, the 'national medical service items' 2012 edition is taken as a reference, the charging items are classified according to the diagnosis and treatment items to form labels, and the label names are expressed as the diagnosis and treatment items (such as II-level nursing and the like) according to the national clinical path expression mode.
The clinical pathway label usage for a specific disease can be calculated, for example, as follows:
the usage rate of the clinical path label of a specific disease is 100% of the number of cases related to the clinical path label of the specific disease/the total number of cases. The number of cases referred to by the label is calculated from the hospital charge item or order details.
In embodiments, the specific illness clinical pathway label physician usage and/or specific illness clinical pathway label department usage may also be calculated:
the usage rate of a doctor in a special clinical path label is 100% of the number of doctor cases related to the special clinical path label/the total number of doctor cases.
The usage rate of a department in a special clinical path label is 100% of the number of the department records related to the special clinical path label/the total number of the department records.
A first disease-specific clinical pathway label recommendation module 108 for generating a first disease-specific recommended removal and/or inclusion and/or replacement label according to a first predetermined disease criterion based on the calculated usage rate of each disease-specific clinical pathway label. That is, applying the "specialty clinical pathway label" against the national version clinical pathway generates a recommendation inclusion/recommendation removal/recommendation alternative based on the national clinical pathway. For example, a "specialty clinical pathway label" that is the same as the name of the item in the national clinical pathway and has a usage rate of less than 30% is a recommended removal label; the special clinical pathway label which is different from the item name in the national clinical pathway but has the use rate of more than or equal to 50 percent is a recommended inclusion label; and for the special disease clinical path label corresponding to the charging item with the scene of the charging item being the operation and the anesthesia, if the utilization rate is more than or equal to 50%, the special disease clinical path label is recommended to be optimized to replace the operation/anesthesia. Criteria for the specific criteria, such as a usage threshold, can be set based on the actual conditions of the hospital.
A first nosocomial clinical pathway generation module 110 for removing and/or including and/or replacing the label according to the first nosocomial recommendation to modify the nosocomial clinical pathway and treating the modified nosocomial clinical pathway as a nosocomial clinical pathway, thereby making the clinical pathway more in line with hospital reality and science.
In an embodiment, the clinical pathway formation system further comprises:
an in-hospital clinical pathway determination module to determine whether there is an in-hospital clinical pathway for the selected disease category. "in-hospital" refers to use in a certain hospital;
and the hospital internal clinical path label utilization rate calculation module is used for responding to the determination of the hospital internal clinical path with the selected disease category, and calculating the utilization rate of each hospital internal clinical path label according to the pre-constructed hospital internal clinical path label, wherein the hospital internal clinical path label represents clinical diagnosis and treatment items and is respectively matched with the charging items or the medical order data of the disease category of the corresponding hospital. Specifically, the name of the item in the clinical path of the patient type in the hospital can be used as each label name of the clinical path in the hospital, and if the hospital has a corresponding relation table of the clinical path of the patient type, the medical order and the charging item, the mapping relation table of the clinical path of the hospital is referred to, and the medical order with consumable material in the category in the mapping relation table and the charging item/medical order corresponding to the item in the clinical path of the hospital after the charging item are removed are the charging item/medical order contained in the clinical path. If the hospital has no corresponding relation table of clinical paths, medical orders and charging items, the items in the clinical paths of the disease are used as names, the items in the clinical paths are distinguished into medicines and other diagnosis and treatment items by combining experience and the expression mode of the items in the clinical paths, for the medicine diagnosis and treatment items, the names of the charging items can be classified and matched to the items in the clinical paths by taking national medical insurance catalogue as reference, for the other diagnosis and treatment items, the medical orders/charging items can be matched to the items in the clinical paths by taking national medical service item 2012 as reference. The matching is similar to the targeting rules for healthcare items in the targeting rules described above. Likewise, a tag may contain multiple charge items or include multiple orders, but a tag may contain only charge items or orders, not both, and only one charge item/order may correspond to a tag. The in-hospital clinical pathway label usage was calculated as follows: the usage rate of the clinical pathway label in a hospital is 100% of the number of cases related to the clinical pathway label in the hospital.
And the hospital clinical pathway label recommendation module is used for generating a hospital recommended removal and/or inclusion and/or replacement label according to the calculated utilization rate of each special disease clinical pathway label and the utilization rate of each hospital clinical pathway label and a preset hospital criterion. For example, a "hospital clinical pathway label" usage rate of less than 30% corresponds to a "specific illness clinical pathway label" of less than 50%, the "hospital clinical pathway label" being a recommended removal label; the usage rate of the special clinical pathway label is more than or equal to 50%, and the corresponding in-hospital clinical pathway label does not belong to the item in the hospital clinical pathway, and the special clinical pathway label is a recommended inclusion label. For a 'special disease clinical path label' of which the scene of the charging item is surgery and anesthesia (the executive department/the order department in the charging detail table is an operating room and an anesthesia department, or the application scene can be judged to be the charging item of surgery/anesthesia according to product use instructions, medical service item interpretation and the like), if the utilization rate is more than or equal to 50%, the 'special disease clinical path label' is recommended to be optimized to replace the surgery/anesthesia; for a "clinical pathway label in the hospital" usage rate of less than 30%, but a "clinical pathway label for a specific disease" usage rate of 50% or more, the "clinical pathway label for a specific disease" is recommended to replace the "clinical pathway label in the hospital". Similarly, criteria within the hospital, such as a usage threshold, may be set based on the actual conditions of the hospital.
An in-hospital clinical pathway update module to update an in-hospital clinical pathway according to the in-hospital recommendation removal and/or inclusion and/or replacement label.
In an embodiment, the clinical pathway formation system further comprises:
the second special clinical pathway label utilization rate calculation module is used for responding to the special clinical pathway without the selected disease category and calculating the utilization rate of each special clinical pathway label according to the pre-constructed special clinical pathway label;
and the second special disease clinical path label recommending module is used for generating a second special disease recommendation inclusion label according to the calculated utilization rate of each special disease clinical path label and a second preset special disease criterion. For example, the labels with the usage rate of the "special clinical pathway label" being greater than or equal to 50% are all recommended inclusion labels;
and the second nosocomial clinical pathway generation module is used for generating a nosocomial clinical pathway according to the second special disease recommendation inclusion label.
In an embodiment, the clinical pathway formation system further comprises an expert review module for accepting a secondary confirmation by an expert of the recommended label. And performing review on recommended inclusion/removal/replacement items by an expert based on clinical experience and a traditional clinical path, judging whether the items are included/removed/replaced, and generating or updating a clinical path based on the result after the review by the expert, wherein the clinical path comprises the optimized items in the clinical path, the associated charging item names and standard schemes (upper limit, lower limit and mean value of the usage).
In an embodiment, the clinical pathway formation system further comprises a viewing module for viewing at least the calculated specific clinical pathway label usage, in-hospital clinical pathway label usage, specific clinical pathway label physician usage, and/or specific clinical pathway label department usage results.
In the embodiment, a recommendation scheme of specific medication, consumables and usage under the clinical path internal diagnosis item can be provided, and particularly, a mode of only controlling the name of an operation in the traditional clinical path is replaced by the recommendation scheme of applying the specific diagnosis and treatment item and the specific medication, consumables and usage to a special scene with high resource consumption such as operation and anesthesia, so that accurate cost control is realized.
FIG. 2 shows a flow chart of a preferred embodiment of a clinical pathway formation method according to the present invention.
In step S202, it is determined whether there is a specific clinical pathway for a disease, wherein the specific clinical pathway is one of national version clinical pathways. If so, the process proceeds to step S204; otherwise, the process proceeds to step S222.
In step S204, the utilization rate of each disease-specific clinical pathway label is calculated according to pre-constructed disease-specific clinical pathway labels, wherein the disease-specific clinical pathway labels represent clinical diagnosis and treatment items and are respectively matched with the charging items or medical order data of the disease category of the corresponding hospital, and each charging item or medical order can only correspond to one disease-specific clinical pathway label.
In step S206, a first disease specific recommendation removal and/or inclusion and/or replacement label is generated according to a first predetermined disease specific criterion based on the calculated usage of each disease specific clinical pathway label.
In step S208, the disease specific clinical pathway is modified according to the first disease specific recommendation by removing and/or including and/or replacing the label and the modified disease specific clinical pathway is taken as the in-hospital clinical pathway.
In step S222, the usage rate of each disease-specific clinical pathway label is calculated according to the pre-constructed disease-specific clinical pathway label.
In step S224, a second specific disease recommendation inclusion label is generated according to a second predetermined specific disease criterion based on the calculated usage of each specific disease clinical pathway label.
In step S226, an in-hospital clinical pathway is generated according to the second specialist recommendation inclusion label.
In an embodiment, the clinical pathway formation method further comprises: determining whether there is an in-hospital clinical pathway for the disease species; in response to determining the in-hospital clinical pathway having the disease category, calculating the utilization rate of each in-hospital clinical pathway label according to pre-constructed in-hospital clinical pathway labels, wherein the in-hospital clinical pathway labels represent clinical treatment items and are respectively matched with charge items or medical order data of the disease category of a corresponding hospital, and each charge item or medical order can only correspond to one in-hospital clinical pathway label; generating recommended removal and/or inclusion and/or replacement labels in the hospital according to the calculated utilization rate of each special clinical pathway label and the utilization rate of each clinical pathway label in the hospital according to preset criteria in the hospital; updating the in-hospital clinical pathway according to the in-hospital recommendation removal and/or inclusion and/or replacement labels.
In another embodiment, the present invention provides a computer-readable storage medium, on which a computer program is stored, where the computer program, when executed by a processor, implements the functions of the system embodiment or other corresponding system embodiments shown and described in connection with fig. 1 or implements the steps of the method embodiment or other corresponding method embodiments shown and described in connection with fig. 2, and is not described herein again.
In another embodiment, the present invention provides a computer device, including a processor, a memory, and a computer program stored in the memory and capable of running on the processor, where the processor, when executing the computer program, implements the functions of the system embodiment or other corresponding system embodiments shown and described in connection with fig. 1 or implements the steps of the method embodiment or other corresponding method embodiments shown and described in connection with fig. 2, and therefore, details are not described herein again.
The various embodiments described herein, or certain features, structures, or characteristics thereof, may be combined as suitable in one or more embodiments of the invention. Additionally, in some cases, the order of steps depicted in the flowcharts and/or in the pipelined process may be modified, as appropriate, and need not be performed exactly in the order depicted. In addition, various aspects of the invention may be implemented using software, hardware, firmware, or a combination thereof, and/or other computer implemented modules or devices that perform the described functions. Software implementations of the present invention may include executable code stored in a computer readable medium and executed by one or more processors. The computer-readable medium may include a computer hard drive, ROM, RAM, flash memory, portable computer storage media such as CD-ROM, DVD-ROM, flash drives, and/or other devices with a Universal Serial Bus (USB) interface, and/or any other suitable tangible or non-transitory computer-readable medium or computer memory on which executable code may be stored and executed by a processor. The present invention may be used in conjunction with any suitable operating system.
As used herein, the singular forms "a", "an" and "the" include plural references (i.e., have the meaning "at least one"), unless the context clearly dictates otherwise. It will be further understood that the terms "has," "includes" and/or "including," when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. The term "and/or" as used herein includes any and all combinations of one or more of the associated listed items.
The foregoing describes some preferred embodiments of the present invention, but it should be emphasized that the invention is not limited to these embodiments, but can be implemented in other ways within the scope of the inventive subject matter. Various modifications and alterations of this invention will become apparent to those skilled in the art without departing from the spirit and scope of this invention.
Claims (10)
1. A clinical pathway formation system, the system comprising:
a specific disease clinical pathway determination module for determining whether a specific disease clinical pathway of a disease category exists, wherein the specific disease clinical pathway is one of national edition clinical pathways;
the first special clinical path label utilization rate calculation module is used for responding to the special clinical path with the disease category and calculating the utilization rate of each special clinical path label according to a pre-constructed special clinical path label, wherein the special clinical path label represents a clinical diagnosis and treatment item and is respectively matched with the charging items or medical advice data of the disease category of a corresponding hospital, and each charging item or medical advice can only correspond to one special clinical path label;
the first special clinical pathway label recommendation module is used for generating first special clinical recommendation removal and/or inclusion and/or replacement labels according to the calculated utilization rate of each special clinical pathway label and a first preset special criterion;
a first nosocomial clinical pathway generation module to remove and/or incorporate and/or replace the label according to the first disease-specific recommendation to modify the disease-specific clinical pathway and take the modified disease-specific clinical pathway as the nosocomial clinical pathway.
2. The system of claim 1, further comprising:
an nosocomial clinical pathway determination module to determine whether there is an nosocomial clinical pathway of the disease category;
the hospital clinical path label utilization rate calculation module is used for responding to the determination of the hospital clinical path with the disease category, and calculating the utilization rate of each hospital clinical path label according to the pre-constructed hospital clinical path label, wherein the hospital clinical path label represents clinical diagnosis and treatment items and is respectively matched with charge items or medical order data of the disease category of the corresponding hospital, and each charge item or medical order can only correspond to one hospital clinical path label;
the hospital clinical pathway label recommendation module is used for generating a hospital recommended removal label and/or an inclusion label and/or a substitution label according to the calculated utilization rate of each special disease clinical pathway label and the utilization rate of each hospital clinical pathway label and a preset hospital criterion;
an in-hospital clinical pathway update module to update the in-hospital clinical pathway according to the in-hospital recommendation removal and/or inclusion and/or replacement label.
3. The system of claim 1, further comprising:
the second special clinical pathway label utilization rate calculation module is used for responding to the special clinical pathway without the disease category and calculating the utilization rate of each special clinical pathway label according to a pre-constructed special clinical pathway label;
the second special disease clinical path label recommending module is used for generating a second special disease recommendation inclusion label according to the calculated utilization rate of each special disease clinical path label and a second preset special disease criterion;
and the second nosocomial clinical pathway generation module is used for generating a nosocomial clinical pathway according to the second special disease recommendation inclusion label.
4. The system according to any one of claims 1-3, further comprising:
and the expert commenting module is used for receiving secondary confirmation of the expert on the recommended label.
5. The system according to any one of claims 1-3, further comprising:
a review module to review at least the calculated clinical pathway label usage results.
6. A method of clinical pathway formation, the method comprising:
determining whether a disease-specific clinical pathway exists for a disease category, wherein the disease-specific clinical pathway is one of national edition clinical pathways;
in response to determining a disease-specific clinical pathway with the disease category, calculating the utilization rate of each disease-specific clinical pathway label according to pre-constructed disease-specific clinical pathway labels, wherein the disease-specific clinical pathway labels represent clinical treatment items and are respectively matched with charge items or medical order data of the disease category of a corresponding hospital, and each charge item or medical order can only correspond to one disease-specific clinical pathway label;
generating a first special disease recommendation removal and/or inclusion and/or replacement label according to the calculated utilization rate of each special disease clinical path label and a first preset special disease criterion;
modifying the disease specific clinical pathway according to the first disease specific recommendation by removing and/or including and/or replacing a label and treating the modified disease specific clinical pathway as an in-hospital clinical pathway.
7. The method of claim 6, further comprising:
determining whether there is an in-hospital clinical pathway for the disease species;
in response to determining the in-hospital clinical pathway having the disease category, calculating the utilization rate of each in-hospital clinical pathway label according to pre-constructed in-hospital clinical pathway labels, wherein the in-hospital clinical pathway labels represent clinical treatment items and are respectively matched with charge items or medical order data of the disease category of a corresponding hospital, and each charge item or medical order can only correspond to one in-hospital clinical pathway label;
generating recommended removal and/or inclusion and/or replacement labels in the hospital according to the calculated utilization rate of each special clinical pathway label and the utilization rate of each clinical pathway label in the hospital according to preset criteria in the hospital;
updating the in-hospital clinical pathway according to the in-hospital recommendation removal and/or inclusion and/or replacement labels.
8. The method according to claim 6 or 7, characterized in that the method further comprises:
in response to determining that there is no disease-specific clinical pathway of the disease species, calculating the utilization rate of each disease-specific clinical pathway label according to pre-constructed disease-specific clinical pathway labels;
generating a second special disease recommendation inclusion label according to the calculated utilization rate of each special disease clinical path label and a second preset special disease criterion;
generating an in-hospital clinical pathway according to the second disease-specific recommendation inclusion label.
9. A computer device comprising a processor, a memory and a computer program stored on and executable on the memory, wherein the processor when executing the computer program realizes the functions of the system according to any of the claims 1-5 or the steps of the method according to any of the claims 6-8.
10. A computer-readable storage medium, on which a computer program is stored which, when being executed by a processor, carries out the functions of the system according to any one of claims 1 to 5 or the steps of the method according to any one of claims 6 to 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110459519.6A CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110459519.6A CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113421639A true CN113421639A (en) | 2021-09-21 |
| CN113421639B CN113421639B (en) | 2023-11-10 |
Family
ID=77711928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110459519.6A Active CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113421639B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115346647A (en) * | 2022-07-26 | 2022-11-15 | 杭州吉音医疗科技有限公司 | Intelligent DIP clinical path planning management information method and system |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0013811D0 (en) * | 1999-06-09 | 2000-07-26 | Curapath Systems Inc | Method for performing activity based costing for health care provider facilities |
| US20040111294A1 (en) * | 2002-12-09 | 2004-06-10 | Mcnally Larry | System and a method for providing integrated access management for peritoneal dialysis and hemodialysis |
| CN101853432A (en) * | 2010-01-25 | 2010-10-06 | 田小平 | System and method for controlling medical performance |
| CN102567607A (en) * | 2010-12-28 | 2012-07-11 | 广州中医药大学第二附属医院 | Clinic path information system |
| CN103679602A (en) * | 2012-09-25 | 2014-03-26 | 大连运邦科技发展有限公司 | Clinical pathway medical management system |
| CN106021967A (en) * | 2016-07-12 | 2016-10-12 | 上海市浦东新区周浦医院 | Data processing method for clinical pathway quality evaluation |
| CN106228023A (en) * | 2016-08-01 | 2016-12-14 | 清华大学 | A kind of clinical path method for digging based on body and topic model |
| CN107038344A (en) * | 2017-04-24 | 2017-08-11 | 大连诺道认知医学技术有限公司 | A kind of disease actual clinical path and standard clinical route comparing method and device |
| CN107798621A (en) * | 2017-08-30 | 2018-03-13 | 平安科技（深圳）有限公司 | Medical diagnosis on disease signal auditing method and device |
| CN108538349A (en) * | 2018-03-28 | 2018-09-14 | 深圳市前海安测信息技术有限公司 | Hospital clinical path based on clinical path variance analysis adjusts system and method |
| CN109785916A (en) * | 2019-01-24 | 2019-05-21 | 柳州市工人医院 | A kind of clinical path system based on information for hospital platform |
| CN110119432A (en) * | 2019-03-29 | 2019-08-13 | 中国人民解放军总医院 | A kind of data processing method for medical platform |
| CN110957013A (en) * | 2018-09-27 | 2020-04-03 | 清华大学 | Method and device for localization of clinical pathways based on genetic algorithm |
| CN111192644A (en) * | 2019-12-11 | 2020-05-22 | 平安医疗健康管理股份有限公司 | Construction method and device of clinical path, computer equipment and storage medium |
| CN111816326A (en) * | 2020-07-22 | 2020-10-23 | 望海康信(北京)科技股份公司 | Hospital operation system |
| CN112185544A (en) * | 2020-09-10 | 2021-01-05 | 浙江传媒学院 | Semantic-based family medical consultation decision support method |
| CN112635030A (en) * | 2020-11-30 | 2021-04-09 | 望海康信(北京)科技股份公司 | Automatic generation system and method for fee control prompt, corresponding equipment and storage medium |
-
2021
- 2021-04-27 CN CN202110459519.6A patent/CN113421639B/en active Active
Patent Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0013811D0 (en) * | 1999-06-09 | 2000-07-26 | Curapath Systems Inc | Method for performing activity based costing for health care provider facilities |
| US20040111294A1 (en) * | 2002-12-09 | 2004-06-10 | Mcnally Larry | System and a method for providing integrated access management for peritoneal dialysis and hemodialysis |
| CN101853432A (en) * | 2010-01-25 | 2010-10-06 | 田小平 | System and method for controlling medical performance |
| CN102567607A (en) * | 2010-12-28 | 2012-07-11 | 广州中医药大学第二附属医院 | Clinic path information system |
| CN103679602A (en) * | 2012-09-25 | 2014-03-26 | 大连运邦科技发展有限公司 | Clinical pathway medical management system |
| CN106021967A (en) * | 2016-07-12 | 2016-10-12 | 上海市浦东新区周浦医院 | Data processing method for clinical pathway quality evaluation |
| CN106228023A (en) * | 2016-08-01 | 2016-12-14 | 清华大学 | A kind of clinical path method for digging based on body and topic model |
| CN107038344A (en) * | 2017-04-24 | 2017-08-11 | 大连诺道认知医学技术有限公司 | A kind of disease actual clinical path and standard clinical route comparing method and device |
| CN107798621A (en) * | 2017-08-30 | 2018-03-13 | 平安科技（深圳）有限公司 | Medical diagnosis on disease signal auditing method and device |
| CN108538349A (en) * | 2018-03-28 | 2018-09-14 | 深圳市前海安测信息技术有限公司 | Hospital clinical path based on clinical path variance analysis adjusts system and method |
| CN110957013A (en) * | 2018-09-27 | 2020-04-03 | 清华大学 | Method and device for localization of clinical pathways based on genetic algorithm |
| CN109785916A (en) * | 2019-01-24 | 2019-05-21 | 柳州市工人医院 | A kind of clinical path system based on information for hospital platform |
| CN110119432A (en) * | 2019-03-29 | 2019-08-13 | 中国人民解放军总医院 | A kind of data processing method for medical platform |
| CN111192644A (en) * | 2019-12-11 | 2020-05-22 | 平安医疗健康管理股份有限公司 | Construction method and device of clinical path, computer equipment and storage medium |
| CN111816326A (en) * | 2020-07-22 | 2020-10-23 | 望海康信(北京)科技股份公司 | Hospital operation system |
| CN112185544A (en) * | 2020-09-10 | 2021-01-05 | 浙江传媒学院 | Semantic-based family medical consultation decision support method |
| CN112635030A (en) * | 2020-11-30 | 2021-04-09 | 望海康信(北京)科技股份公司 | Automatic generation system and method for fee control prompt, corresponding equipment and storage medium |
Non-Patent Citations (2)
| Title |
|---|
| PANELLA, M: "Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial", QUALITY & SAFETY IN HEALTH CARE, vol. 18, no. 5, pages 369 - 373 * |
| 阎惠中;: "关于临床路径的三个问题", 中国医院, no. 12, pages 32 - 34 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115346647A (en) * | 2022-07-26 | 2022-11-15 | 杭州吉音医疗科技有限公司 | Intelligent DIP clinical path planning management information method and system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113421639B (en) | 2023-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101107607B (en) | Procedural medicine workflow management | |
| US8527293B2 (en) | Method and system for supporting clinical decision-making | |
| US20050273370A1 (en) | System and method for determining risk management solutions | |
| JP2012510670A (en) | System and method for extracting, retaining and transmitting clinical elements in widget-type applications | |
| Hertzum | Breakdowns in collaborative information seeking: A study of the medication process | |
| JP2012533117A (en) | Medical history system | |
| US20110295873A1 (en) | Methods and apparatus to enhance queries in an affinity domain | |
| US20080183497A1 (en) | Method and apparatus for internet-based community of health experts | |
| US20180350466A1 (en) | Longitudinal health patient profile for incidental findings | |
| McLaughlin et al. | Tracking and sustaining improvement initiatives: leveraging quality dashboards to lead change in a neurosurgical department | |
| Caples | Intensive care unit telemedicine care models | |
| US20160012189A1 (en) | Method and System for Patient Treatment Management Using Interactive Digital Best Practice Treatment Guidelines | |
| Hsu et al. | An integrated, ontology-driven approach to constructing observational databases for research | |
| McCormack et al. | Electronic health records and pulmonary function data: developing an interoperability roadmap. An official American Thoracic Society workshop report | |
| EP2782056A1 (en) | Personalised medicine system for rating patient characteristics | |
| Saab et al. | Capabilities of gemini models in medicine | |
| Narula | Are we up to speed? From big data to rich insights in CV imaging for a hyperconnected world | |
| CN113421639A (en) | Clinical pathway formation system, method, and corresponding apparatus and storage medium | |
| Khodambashi | Lean analysis of an intra-operating management process-identifying opportunities for improvement in health information systems | |
| US20150248529A1 (en) | Healthcare management system | |
| RU2657856C2 (en) | Method for stepwise review of patient care | |
| US20120131436A1 (en) | Automated report generation with links | |
| Lee et al. | Developing hierarchical standardized home care nursing statements using nursing standard terminologies | |
| Ema et al. | Proposal for type classification for building trust in medical artificial intelligence systems | |
| US20160063211A1 (en) | Systems and methods for modeling medical condition information |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |